Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Every year, more than 67,000 people are diagnosed with pancreatic cancer. In most cases, the disease has spread, and patients ...

A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...

SEATTLE — Pancreatic cancer is considered one of the deadliest cancers, with a five-year survival rate of just 13 percent, by ...

The signs of pancreatic cancer are very subtle and often overlooked. Dr Sethi shares seven things to look out for to detect ...

Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that targets the root cause of how the disease exists and spreads. Arizona ...

Revolution Medicines has spent nearly a decade chasing what Dr. Alan Sandler, the Chief Development Officer at the company, ...

Lynch syndrome, an autosomal dominant disorder caused by defective DNA mismatch repair genes, is linked to early-onset colorectal, ovarian, gastric, urinary tract and, less commonly, small bowel, ...

Scottish sports journalist and content creator. After running his own soccer-related projects, in 2022 he joined Diario AS, where he mainly reports on the biggest news from around Europe’s leading ...